Basic Malaria Research

We acquire new functional and mechanistic insight into processes linked to the essential biology of malaria blood stage parasites. These parasite forms are responsible for all malaria-related morbidity and mortality as well as for the transmission of parasites between humans via the mosquito vector. We place particular emphasis on

  1. Investigating the molecular mechanisms underlying parasite-induced red blood cell remodelling, through which infected red blood cells adopt pathogenic traits
  2. Understanding the transcriptional and epigenetic mechanisms responsible for antigenic variation and sexual conversion, which facilitate chronic blood infection and parasite transmission, respectively; and
  3. The identification and characterization of parasite ligands required for red blood cell invasion and their cognate invasion-inhibitory antibodies.

We further engage in elucidating mechanisms of action of anti-malarial drugs and in identifying immunological response signatures associated with native and adaptive anti-malarial immunity in vivo.

Related Publications

All Publications

Hellingman A et al. Using next generation chemiluminescent probes to improve the Plasmodium falciparum in vitro parasite reduction ratio (PRR) assay. ACS Infect Dis. 2026(in press). DOI: 10.1021/acsinfecdis.5c00924

Brancucci N.M.B et al. An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs. Nat Commun. 2025;16:6884. DOI: 10.1038/s41467-025-62014-3

Bravo P et al. A novel antimalarial agent that inhibits protein synthesis in Plasmodium falciparum. Angew Chem Int Ed Engl. 2025;64(49):e202514085. DOI: 10.1002/anie.202514085

Darif N.D et al. BioMalPar XX: looking back on, and forward from, 20 years of malaria research. Trends Parasitol. 2024;40(8):651-656. DOI: 10.1016/j.pt.2024.06.012

Day C.J et al. The essential malaria protein PfCyRPA targets glycans to invade erythrocytes. Cell Rep. 2024;43(4):114012. DOI: 10.1016/j.celrep.2024.114012